Concepedia

Robert Shorr

RS

Statistics

Publications

50

Citations

2.9K

H-Index

25

Active since

1978

Affiliations

Enzon Pharmaceuticals (United States)(Current)

Duke Medical Center

Duke University Hospital

BioChem Technology (United States)

Howard Hughes Medical Institute

Robert Shorr is an author at Enzon Pharmaceuticals (United States) specializing in life sciences, biochemistry, and medicine.

Publications per year

1978–2014

50

Publications

50

The therapeutic value of poly(ethylene glycol)-modified proteins

Mary L. Nucci, Robert Shorr, Abraham Abuchowski · Advanced Drug Delivery Reviews · 1991 · 278 citations

, , +14

Molecular cloning and expression of the major protein kinase C substrate of platelets

Michael Tyers, Richard A. Rachubinski, Mary I. Stewart et al. · Nature · 1988 · 254 citations

, , +16

Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor.

Jeffrey M. Stadel, P Nambi, Robert Shorr et al. · Proceedings of the National Academy of Sciences · 1983 · 247 citations · Full text

, , +15

Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo

Zuzana Zachar, James F. Marecek, Claudia Maturo et al. · Journal of Molecular Medicine · 2011 · 220 citations

, , +12

Mammalian .beta.2-adrenergic receptor: purification and characterization

Jeffrey Benovic, Robert Shorr, Marc G. Caron et al. · Biochemistry · 1984 · 205 citations

, , +6

1–5 of 50